BiotechTube

TRC150094

Phase 1/2Completed
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Metabolic Cardiovascular Syndrome

Conditions

Metabolic Cardiovascular Syndrome

Trial Timeline

Nov 1, 2011 → —

NCT ID
NCT01408667

About TRC150094

TRC150094 is a phase 1/2 stage product being developed by Torrent Pharmaceuticals for Metabolic Cardiovascular Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT01408667. Target conditions include Metabolic Cardiovascular Syndrome.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT01408667Phase 1/2Completed

Competing Products

20 competing products in Metabolic Cardiovascular Syndrome

See all competitors
ProductCompanyStageHype Score
Telmisartan 40mg + Rosuvastatin 20mg + Telmisartan 80mg + Rosuvastatin 20mg + Telmisartan 40mg, 80 mg + Rosuvastatin 20mgYuhanApproved
85
Olmesartan medoxomil tablets low dose + Olmesartan medoxomil tablets high dose + AmlodipineDaiichi SankyoPhase 3
77
olmesartan medoxomil + placebo + olmesartan medoxomil + olmesartan medoxomilDaiichi SankyoPhase 3
77
14C-labeled YM178Astellas PharmaPhase 1
33
LY518674Eli LillyPhase 2
52
Tirzepatide + Retatrutide + PlaceboEli LillyPhase 3
77
Metformin + PlaceboEli LillyApproved
85
Tirzepatide + SemaglutideEli LillyPre-clinical
23
LY3849891 + PlaceboEli LillyPhase 1
33
Henagliflozin 10 mg daily + Metformin 1700 mg dailyJiangsu Hengrui MedicineApproved
85
RosuvastatinAstraZenecaPhase 3
77
Rosuvastatin + AtorvastatinAstraZenecaApproved
85
AZD2693 + PlaceboAstraZenecaPhase 1
33
RosuvastatinAstraZenecaPhase 3
77
Rosuvastatin + AtorvastatinAstraZenecaPhase 3
77
rosuvastatinAstraZenecaApproved
85
EfinopegdutideMerckPhase 2
52
MK0767 + Comparator: fenofibrate + Comparator: Placebo (unspecified)MerckPhase 2
52
Vericiguat + PlaceboMerckPhase 2
52
MetforminMerckPhase 2
52

Other Products from Torrent Pharmaceuticals

TRC041266 + PlaceboPhase 3
77
Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) + ACZONE® (dapsone) gel, 7.5% (Allergan, INC.)Phase 3
77
TRC150094 + PlaceboPhase 3
77
Losartan Potassium TabletsPhase 1
33
Rabeprazole sodium 20 mg Delayed Release tabletPhase 1
33